A novel, six-electrode renal denervation (RDN) device showed significantly reduced office systolic blood pressure at 6 months post-procedure in patients with uncontrolled hypertension despite taking antihypertensive medication as compared to patients who underwent a sham procedure, according to new randomized trial results.